| scholarly article | Q13442814 |
| P356 | DOI | 10.1176/AJP.140.8.1048 |
| P698 | PubMed publication ID | 6869591 |
| P2093 | author name string | Holland J | |
| Glass E | |||
| Massie MJ | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | delirium | Q160796 |
| P1104 | number of pages | 3 | |
| P304 | page(s) | 1048-1050 | |
| P577 | publication date | 1983-08-01 | |
| P1433 | published in | American Journal of Psychiatry | Q1935368 |
| P1476 | title | Delirium in terminally ill cancer patients | |
| P478 | volume | 140 |
| Q44313620 | A mono-institutional prospective study on the effectiveness of a specialist psychotherapeutic intervention (POI) started at the diagnosis of cancer |
| Q48334306 | A prospective study of delirium in elderly patients admitted to a psychiatric hospital. |
| Q48308721 | Acute confusion in patients with systemic cancer |
| Q33900209 | Advances in pain management for older adult patients |
| Q44342934 | Agitated Terminal Delirium and Association with Partial Opioid Substitution and Hydration |
| Q37959135 | An open trial of aripiprazole for the treatment of delirium in hospitalized cancer patients |
| Q53512626 | Are special ethical guidelines needed for palliative care research? |
| Q35105885 | Assessing Decision-Making Capacity in the Setting of Palliative Care Research |
| Q51969310 | Assessing delirium in cancer patients: the Italian versions of the Delirium Rating Scale and the Memorial Delirium Assessment Scale. |
| Q38223435 | Chemotherapeutic drugs that penetrate the blood-brain barrier affect the development of hyperactive delirium in cancer patients |
| Q36728558 | Clarifying delirium management: practical, evidenced-based, expert recommendations for clinical practice |
| Q36440120 | Clinical practice guidelines for the management of psychosocial distress at the end of life |
| Q53738217 | Combined use of tricyclic antidepressants and neuroleptics in the management of terminally ill children: a report on three cases. |
| Q40704074 | Common psychiatric disorders in cancer patients. II. Anxiety and acute confusional states |
| Q74657007 | Complicated delirium in a cancer patient successfully treated with olanzapine |
| Q34555917 | Contribution to variability in response to opioids |
| Q38158303 | Deathbed wills: assessing testamentary capacity in the dying patient |
| Q39354483 | Decision making in palliative radiation therapy: reframing hope in caregivers and patients with brain metastases |
| Q33917161 | Delirium and severe illness: Etiologies, severity of delirium and phenomenological differences. |
| Q35566442 | Delirium in Hospital: An Underreported Event at Discharge |
| Q57098356 | Delirium in Terminal Cancer |
| Q33925658 | Delirium in advanced age and dementia: A prolonged refractory course of delirium and lower functional status. |
| Q38139694 | Delirium in hospitalized elderly |
| Q44197109 | Delirium in patients undergoing hematopoietic stem cell transplantation |
| Q34778975 | Delirium in patients with advanced cancer |
| Q33900229 | Delirium in the terminally ill. |
| Q34720007 | Delirium presenting with symptoms of depression |
| Q44458117 | Delirium superimposed on dementia versus delirium in the absence of dementia: phenomenological differences |
| Q45225628 | Delirium, depression, and anxiety |
| Q64980628 | Delirium: diagnosis and management. |
| Q71709774 | Delirium: is the confusion slowly clearing up |
| Q35692859 | End-of-life care in geriatric psychiatry |
| Q33997289 | Ethical decisions in perioperative elder care |
| Q91807667 | Frequency, Outcomes, and Associated Factors for Opioid-Induced Neurotoxicity in Patients with Advanced Cancer Receiving Opioids in Inpatient Palliative Care |
| Q36893010 | Genetic variation and cognitive dysfunction in opioid-treated patients with cancer |
| Q30416693 | Hospice and palliative care |
| Q47882386 | Identification of the predictors of cognitive impairment in patients with cancer in palliative care: a prospective longitudinal analysis |
| Q40494396 | Identifying patients at risk for, and treatment of major psychiatric complications of cancer |
| Q51848824 | Impact of delirium on decision-making capacity after hematopoietic stem-cell transplantation. |
| Q47606087 | Impact of pneumonia on hyperactive delirium in end-stage lung cancer patients |
| Q43886110 | Increased plasma morphine metabolites in terminally ill cancer patients with delirium: an intra-individual comparison |
| Q49095409 | Involvement of a Psychiatric Consultation Service in a Palliative Care Team at the Japanese Cancer Center Hospital |
| Q36368474 | Minor cognitive impairments in cancer patients magnify the effect of caregiver preferences on end-of-life care |
| Q33932066 | Multidisciplinary care of the terminally ill patient |
| Q40699595 | Nonopioid agents for treatment of acute and subacute pain |
| Q34282523 | Pain assessment and management |
| Q37382797 | Palliating delirium in patients with cancer |
| Q33997294 | Palliative care and end-of-life issues |
| Q33900234 | Palliative care for advanced dementia |
| Q41121597 | Palliative medicine and the medical oncologist. Defining the purview of care |
| Q44858923 | Pemoline. An alternative psychostimulant for the management of depressive disorders in cancer patients |
| Q37944584 | Perioperative psychiatric considerations in the elderly. |
| Q24803799 | Predisposing factors for delirium in the surgical intensive care unit |
| Q40621814 | Preventing Delirium at the End of Life: Lessons From Recent Research |
| Q53558236 | Psychiatric aspects of excellent end-of-life care. Ad Hoc Committee on End-of-Life Care. The Academy of Psychosomatic Medicine. |
| Q34537787 | Psychiatric dimensions of palliative care |
| Q40593303 | Psychiatric disorder in a palliative care unit |
| Q41121677 | Psychiatric emergencies in terminally ill cancer patients |
| Q35579736 | Psychiatric issues in older cancer patients |
| Q37172050 | Psychiatric issues in palliative care: recognition of delirium in patients enrolled in hospice care |
| Q34506543 | Psychiatric problems of AIDS inpatients at the New York Hospital: preliminary report |
| Q41151326 | Psychiatry and physician-assisted suicide |
| Q74528631 | Psychosocial aspects of palliative care |
| Q60621970 | Psychosocial problems secondary to cancer |
| Q43995957 | Quality of Life in Clinical and Research Palliative Medicine |
| Q71942830 | Reversible delirium in terminally ill patients |
| Q51946773 | Risk factors for development of delirium among oncology patients. |
| Q35120883 | Role of nuclear factor κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents |
| Q35772261 | Successful treatment of Wernicke encephalopathy in terminally ill cancer patients: report of 3 cases and review of the literature |
| Q73965279 | Symptom prevalence in the last week of life |
| Q84778995 | Symptoms of depression and delirium assessed serially in palliative-care inpatients |
| Q40488576 | The Frequency, Characteristics, and Outcomes Among Cancer Patients With Delirium Admitted to an Acute Palliative Care Unit |
| Q52003077 | The Memorial Delirium Assessment Scale. |
| Q52073653 | The assessment of pain intensity in patients with cognitive failure: A preliminary report |
| Q93538905 | The cancer patient with pain: psychiatric complications and their management |
| Q34483395 | The clinical use of Kampo medicines (traditional Japanese herbal treatments) for controlling cancer patients' symptoms in Japan: a national cross-sectional survey |
| Q37258375 | The cognitive effects of opioids in cancer: a systematic review |
| Q36440129 | The delirium subtypes: a review of prevalence, phenomenology, pathophysiology, and treatment response |
| Q48219983 | The effects of exercise therapy on delirium in cancer patients: a retrospective study |
| Q92654474 | The incidence and prevalence of delirium across palliative care settings: A systematic review |
| Q34580479 | The panorama of opioid-related cognitive dysfunction in patients with cancer: a critical literature appraisal |
| Q37169941 | The preventative role of exogenous melatonin administration to patients with advanced cancer who are at risk of delirium: study protocol for a randomized controlled trial |
| Q77832511 | The use of phenobarbitone in the management of agitation and seizures at the end of life |
| Q84507890 | Treatment characteristics of delirium superimposed on dementia |
| Q39853433 | Treatment of Delirium With Quetiapine |
| Q77335204 | Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients |
| Q71709787 | Usage of haloperidol for delirium in cancer patients |
| Q39460710 | Use of psychotropics in cancer patients |
Search more.